Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Marksteiner

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Neuroreport|July 17, 2004
Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodiesChristian Brenneis, Gregor K Wenning, Karl E Egger, et al.
Frontiers in Aging Neuroscience|March 2, 2026
Plasma phospho-tau 217 outperforms plasma phospho-tau 181 analyzed with Lumipulse in detecting Alzheimer's dementia in a real-world memory clinic populationMichaela Defrancesco, Elke R Gizewski, Ruth Steiger, et al.
Journal of Autism and Developmental Disorders|November 3, 2012
Brief report: CANTAB performance and brain structure in pediatric patients with Asperger syndromeLiane Kaufmann, Sibylle Zotter, Silvia Pixner, et al.
Wiener Klinische Wochenschrift|September 5, 2025
Resources of Austrian hospital-based departments of neurology and psychiatry for new amyloid-antibody therapies in early Alzheimer dementia : A survey of the Austrian Alzheimer SocietyGerhard Ransmayr, Edith Eicher, Jürgen Mraczansky, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutationsMichael Willis, Walter A Kaufmann, Georg Wietzorrek, et al.
Neurobiology of Aging|April 28, 2009
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's diseaseJosef Marksteiner, Georg Kemmler, Elisabeth M Weiss, et al.
Journal of the International Neuropsychological Society : JINS|October 22, 2011
Influence of serotonin transporter genotype and catechol-O-methyltransferase Val158Met polymorphism on recognition of emotional facesMichaela Defrancesco, Harald Niederstätter, Walther Parson, et al.
Plos One|August 14, 2024
Predictive value of somatic and functional variables for cognitive deterioration for early-stage patients with Alzheimer's Disease: Evidence from a prospective registry on dementiaLiane Kaufmann, Tilman Gruenbaum, Roman Janssen, et al.
Experimental Gerontology|January 16, 2004
Chromogranin peptides in Alzheimer's diseaseTheresa Lechner, Christine Adlassnig, Christian Humpel, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|October 2, 2008
[Therapy of Alzheimer's disease: current status and future development]Reinhold Schmidt, Frauke Neff, Christian Lampl, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Neuroreport|July 17, 2004
Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodiesChristian Brenneis, Gregor K Wenning, Karl E Egger, et al.
Frontiers in Aging Neuroscience|March 2, 2026
Plasma phospho-tau 217 outperforms plasma phospho-tau 181 analyzed with Lumipulse in detecting Alzheimer's dementia in a real-world memory clinic populationMichaela Defrancesco, Elke R Gizewski, Ruth Steiger, et al.
Journal of Autism and Developmental Disorders|November 3, 2012
Brief report: CANTAB performance and brain structure in pediatric patients with Asperger syndromeLiane Kaufmann, Sibylle Zotter, Silvia Pixner, et al.
Wiener Klinische Wochenschrift|September 5, 2025
Resources of Austrian hospital-based departments of neurology and psychiatry for new amyloid-antibody therapies in early Alzheimer dementia : A survey of the Austrian Alzheimer SocietyGerhard Ransmayr, Edith Eicher, Jürgen Mraczansky, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutationsMichael Willis, Walter A Kaufmann, Georg Wietzorrek, et al.
Neurobiology of Aging|April 28, 2009
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's diseaseJosef Marksteiner, Georg Kemmler, Elisabeth M Weiss, et al.
Journal of the International Neuropsychological Society : JINS|October 22, 2011
Influence of serotonin transporter genotype and catechol-O-methyltransferase Val158Met polymorphism on recognition of emotional facesMichaela Defrancesco, Harald Niederstätter, Walther Parson, et al.
Plos One|August 14, 2024
Predictive value of somatic and functional variables for cognitive deterioration for early-stage patients with Alzheimer's Disease: Evidence from a prospective registry on dementiaLiane Kaufmann, Tilman Gruenbaum, Roman Janssen, et al.
Experimental Gerontology|January 16, 2004
Chromogranin peptides in Alzheimer's diseaseTheresa Lechner, Christine Adlassnig, Christian Humpel, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|October 2, 2008
[Therapy of Alzheimer's disease: current status and future development]Reinhold Schmidt, Frauke Neff, Christian Lampl, et al.
Pageof 15